Jazz Pharmaceuticals plc 10-K for FY2025
Jazz Pharmaceuticals plc (JAZZ)
10-K
2026-02-24
For: 2025-12-31
View Original
Added on
April 08, 2026
About this 10-K
Jazz Pharmaceuticals plc filed this 10-K on February 24, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $4.27B
- up 4.9% from $4.07B a year earlier
- Net loss
- $356.15M
- compared with net income of $560.12M a year earlier
- Diluted EPS
- -$5.84
- compared with $8.65 a year earlier